Latest Integration News

Raptis Group Limited has voluntarily suspended trading on the ASX as it prepares to announce a significant share placement and entitlement offer, signaling a pivotal moment for the company’s capital structure.

Botanix Pharmaceuticals has clarified that recent share price movements are linked to a rumored US executive order on drug pricing, confirming no undisclosed material information. The company reassures investors of compliance with ASX disclosure rules amid market speculation.

ARC Funds Limited has acquired a controlling interest in The Term Deposit Shop, bolstering its position in the online cash investment space while raising $600,000 in equity and $800,000 in debt financing.

Cleo Diagnostics has completed alpha testing of its ovarian cancer pre-surgical triage assay kits, confirming robust performance and differentiation between benign and malignant disease. The company now moves forward to assay optimisation and manufacturing scale-up, edging closer to FDA submission and commercial launch.

AdNeo Limited is acquiring Learnt Global in a $5.775 million scrip deal, significantly expanding its footprint in Australia’s fast-growing vocational education market. The combined entity forecasts doubling revenue and achieving positive EBITDA by mid-2026.

AdNeo Limited announces a transformative all-scrip acquisition of Learnt Global Group, poised to double its annual revenue and unlock significant growth opportunities. The deal is backed by a $1.5 million equity placement and strategic board appointments.

ClearVue Technologies has inked a five-year exclusive manufacturing and distribution agreement with New Zealand’s Viridian Glass, marking its strategic entry into the New Zealand market with solar-integrated glazing solutions.

Ridley Corporation announces a $300 million acquisition of Incitec Pivot Fertilisers Distribution, aiming to boost earnings and diversify its agricultural services portfolio. The deal includes a $125 million equity raise and strategic supply agreements.

C29 Metals has identified several promising multi-commodity exploration targets in Kazakhstan through advanced airborne geophysical surveys, setting the stage for extensive fieldwork and drilling later this year.

Mayne Pharma Group has acknowledged a delayed filing of a director's interest notice due to administrative oversight and is taking steps to reinforce compliance with ASX disclosure rules.

TasFoods reported a $10.7 million net loss for FY2024, challenged by an oversupplied poultry market and a significant asset impairment. The company is pivoting towards growth in pet treats and dairy exports to stabilize its future.

Vitura Health reports sustained revenue and EBITDA growth in Q3 FY2025, driven by recent acquisitions and operational improvements, positioning the company well for FY2026.